$47.94
9.90% day before yesterday
Nasdaq, Dec 20, 10:05 pm CET
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Twist Bioscience Corp. Stock price

$47.94
+6.83 16.61% 1M
-0.80 1.64% 6M
+11.08 30.06% YTD
+12.87 36.70% 1Y
-33.80 41.35% 3Y
+24.19 101.85% 5Y
+33.94 242.43% 10Y
Nasdaq, Closing price Fri, Dec 20 2024
+4.32 9.90%
ISIN
US90184D1000
Symbol
TWST
Sector
Industry

Key metrics

Market capitalization $2.85b
Enterprise Value $2.65b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 8.48
P/S ratio (TTM) P/S ratio 9.09
P/B ratio (TTM) P/B ratio 5.97
Revenue growth (TTM) Revenue growth 27.69%
Revenue (TTM) Revenue $312.97m
EBIT (operating result TTM) EBIT $-175.90m
Free Cash Flow (TTM) Free Cash Flow $-69.17m
Cash position $276.40m
EPS (TTM) EPS $-3.60
P/E forward negative
P/S forward 7.62
EV/Sales forward 7.11
Short interest 20.10%
Show more

Is Twist Bioscience Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Twist Bioscience Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Twist Bioscience Corp. forecast:

10x Buy
83%
1x Hold
8%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Twist Bioscience Corp. forecast:

Buy
83%
Hold
8%
Sell
8%

Financial data from Twist Bioscience Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
313 313
28% 28%
100%
- Direct Costs 180 180
16% 16%
57%
133 133
49% 49%
43%
- Selling and Administrative Expenses 187 187
17% 17%
60%
- Research and Development Expense 91 91
15% 15%
29%
-144 -144
18% 18%
-46%
- Depreciation and Amortization 31 31
3% 3%
10%
EBIT (Operating Income) EBIT -176 -176
15% 15%
-56%
Net Profit -209 -209
2% 2%
-67%

In millions USD.

Don't miss a Thing! We will send you all news about Twist Bioscience Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Twist Bioscience Corp. Stock News

Neutral
Business Wire
3 days ago
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 5:15 p.m. Pacific Time in S...
Positive
Seeking Alpha
23 days ago
Twist Bioscience's SynBio and NGS segments continue to generate strong growth, despite macro challenges. The prospects of the biopharma segment are uncertain, highlighted by the sale of milestones and royalties to XOMA for a small amount. Twist's margins continue to improve, and the company now appears to be on a path to cash flow breakeven over the next few years.
Positive
Seeking Alpha
about one month ago
Twist Biosciences just posted a solid Q4, which had the stock rising in trading Monday. However, despite impressive sales growth, Twist Biosciences remains unprofitable, with projected losses for several years even as revenues rise. The company does have a solid balance sheet and north of $1.2 billion in net loss carry forwards.
More Twist Bioscience Corp. News

Company Profile

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

Head office United States
CEO Emily Leproust
Employees 923
Founded 2013
Website www.twistbioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today